Dysbindin-1 Involvement in Schizophrenia and Cognitive Function

Dysbindin-1, a protein encoded by the DTNBP1 gene, plays a central role in synaptic transmission and neuronal development within key brain regions implicated in schizophrenia. Reduced levels of dysbindin-1 have been consistently observed in the dorsolateral prefrontal cortex and hippocampus of individuals with schizophrenia, correlating with deficits in working memory, executive function and long-term memory retention. At the molecular level, dysbindin-1 regulates the trafficking and signalling of dopamine D2 and D3 receptors, glutamate NMDA and metabotropic glutamate receptors, and influences the biogenesis of synaptic vesicles via interaction with the BLOC-1 complex. These actions underpin neuroplastic changes critical for cognitive processing. Genetic variation in DTNBP1 modulates the balance of receptor isoforms and synaptic proteins, offering insight into individual differences in cognitive symptoms and treatment response.

Research from Nature Portfolio

Variations in the DTNBP1 gene have been shown to predict cognitive responses to antipsychotic treatment, revealing that individuals harbouring alleles associated with lower dysbindin-1 expression exhibit enhanced improvements in executive tasks. This effect arises from an altered ratio of short and long dopamine D2 receptor isoforms, shifting presynaptic D2 signalling in the prefrontal cortex and thereby modulating dopamine release during cognitive engagement. These findings illuminate a pharmacogenetic mechanism whereby dysbindin-1 influences the efficacy of antipsychotic drugs on cognition and suggest a route to personalised therapeutic strategies in schizophrenia.

Research from all publishers

A multidisciplinary study of sex differences in dysbindin-1 function has demonstrated male-specific impairments in working memory linked to interactions between DTNBP1 variants and catechol-O-methyltransferase (COMT) activity. In male mice and humans, reduced dysbindin-1 levels coupled with COMT-mediated dopamine degradation in the prefrontal cortex lead to diminished dorsolateral prefrontal activity during memory tasks, whereas oestrogen appears to buffer these effects in females. This work highlights the need for sex-informed stratification in clinical management.

Another investigation into the interplay of dysbindin-1 and dopamine D3 receptors in mice revealed that combined haploinsufficiency of D3 and DTNBP1 genes restores expression of key neuroplasticity genes (GRIN1, GRIN2A) and elevates brain-derived neurotrophic factor levels across the hippocampus, striatum and prefrontal cortex. However, D3 hypofunction alone increased pro-inflammatory cytokines, indicating that balanced D3–dysbindin-1 interactions are essential for synchronising neuroplastic and neuroinflammatory pathways in schizophrenia models.

Dysbindin-1 Involvement in Schizophrenia and Cognitive Function publication trend

The graph below shows the total number of articles in dysbindin-1 involvement in schizophrenia and cognitive function across all publications each year (not limited to Nature Index journals).

Technical terms

Dysbindin-1: A protein encoded by DTNBP1 involved in synaptic vesicle formation and receptor trafficking, critical for cognitive processes.

Epistatic interaction: A genetic phenomenon in which the effect of one gene (e.g. DTNBP1) is modified by one or more other genes (e.g. COMT).

Dorsolateral prefrontal cortex: A region of the cerebral cortex essential for executive functions such as working memory and decision-making.

Neuroplasticity: The capacity of neurons and synapses to undergo structural and functional change in response to experience or injury.

BLOC-1 complex: A multi-protein assembly critical for the biogenesis of lysosome-related organelles and endosomal trafficking in neurons.

References

1. Sex dimorphism controls dysbindin-related cognitive dysfunctions in mice and humans with the contribution of COMT. Molecular Psychiatry (2024).
2. The Role of Dopamine D3 Receptors, Dysbindin, and Their Functional Interaction in the Expression of Key Genes for Neuroplasticity and Neuroinflammation in the Mouse Brain. International Journal of Molecular Sciences (2023).
3. Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment. Nature Communications (2018).
4. Dysbindin-1 Involvement in the Etiology of Schizophrenia. International Journal of Molecular Sciences (2017).